Cancer Clinical Investigation

Search results

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Launches Center Of Excellence To Enhance Treatment And Care For Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Alligator Bioscience and Aptevo Therapeutics Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study

  Marron, T.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Aptevo Therapeutics and Alligator Bioscience Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study

  Marron, T.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Aptevo Therapeutics and Alligator Bioscience Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study

  Marron, T.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Lenvatinib, Pembrolizumab Plus TACE Improves PFS in Intermediate-Stage HCC

  Llovet, J.

  15/09/24

  1 item of Media coverage

  Press/Media

• Lenvatinib, Pembrolizumab Plus TACE Improves PFS in Intermediate-Stage HCC

  Llovet, J.

  15/09/24

  1 item of Media coverage

  Press/Media

• KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Combination With Transarterial Chemoembolization Significantly Improved Progression-Free Survival Compared to TACE Alone in Patients With Unresectable, Non-Metastatic Hepatocellular Carcinoma

  Llovet, J.

  14/09/24

  1 item of Media coverage

  Press/Media

• KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Combination With Transarterial Chemoembolization Significantly Improved Progression-Free Survival Compared to TACE Alone in Patients With Unresectable, Non-Metastatic Hepatocellular Carcinoma

  Llovet, J.

  14/09/24

  1 item of Media coverage

  Press/Media

• KEYTRUDA(TM) (pembrolizumab) Plus LENVIMA(TM) (lenvatinib) in Combination With Transarterial Chemoembolization Significantly Improved Progression-Free Survival Compared to TACE Alone in Patients With Unresectable, Non-Metastatic Hepatocellular Carcinoma

  Llovet, J.

  14/09/24

  1 item of Media coverage

  Press/Media